MedPath

University Health Network

University Health Network logo
πŸ‡¨πŸ‡¦Canada
Ownership
Private
Established
1999-01-01
Employees
10K
Market Cap
-
Website
http://www.uhn.ca

Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

Phase 2
Completed
Conditions
Neuroendocrine Tumors
Interventions
First Posted Date
2008-01-31
Last Posted Date
2019-02-19
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
22
Registration Number
NCT00605566
Locations
πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Phase 2
Completed
Conditions
Nasopharyngeal Cancer
Interventions
Drug: Carboplatin/Cisplatin
First Posted Date
2008-01-29
Last Posted Date
2019-02-28
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
20
Registration Number
NCT00603915
Locations
πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

Hippocampal Radiation Exposure and Memory

Completed
Conditions
Trigeminal Neuralgia
Arteriovenous Malformation
Schwannoma
First Posted Date
2008-01-29
Last Posted Date
2016-06-23
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
1
Registration Number
NCT00603694
Locations
πŸ‡¨πŸ‡¦

Joey & Toby Tanenbaum Gamma Knife Centre, Toronto Western Hospital, Toronto, Ontario, Canada

Exploring the Role of 3T MRI in Gamma Knife Radiosurgery

Completed
Conditions
Brain Metastases
First Posted Date
2008-01-28
Last Posted Date
2016-06-23
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
45
Registration Number
NCT00602992
Locations
πŸ‡¨πŸ‡¦

Toronto Western Hospital, Toronto, Ontario, Canada

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

Phase 2
Terminated
Conditions
Prostatic Neoplasms
Fatigue
Interventions
First Posted Date
2008-01-15
Last Posted Date
2014-06-04
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
33
Registration Number
NCT00593853
Locations
πŸ‡¨πŸ‡¦

UHN Princess Margaret Hospital, Toronto, Ontario, Canada

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Not Applicable
Conditions
Hearing Loss
Ototoxicity
Interventions
Drug: placebo
First Posted Date
2007-12-21
Last Posted Date
2007-12-21
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
110
Registration Number
NCT00578760
Locations
πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

Somatosensory Processing in Focal Hand Dystonia

Not Applicable
Conditions
Focal Hand Dystonia
Musician's Dystonia
Writer's Cramp
Dystonic Cramp
Interventions
Other: Tactile training + sham rTMS
Other: Tactile training + rTMS
First Posted Date
2007-12-21
Last Posted Date
2007-12-21
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
24
Registration Number
NCT00579033
Locations
πŸ‡¨πŸ‡¦

Toronto Western Hosptial, Toronto, Ontario, Canada

Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia

Not Applicable
Completed
Conditions
Dysphagia
Deglutition Disorders
Stroke
Interventions
Other: TOR-BSSTΒ© Refresher Training
First Posted Date
2007-12-11
Last Posted Date
2012-01-11
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
96
Registration Number
NCT00570557
Locations
πŸ‡¨πŸ‡¦

Alberta Health Services - Capital Health (University of Alberta Hospital, Royal Alexandra Hospital), Edmonton, Alberta, Canada

πŸ‡ΊπŸ‡Έ

Our Lady of Lourdes Hospital, Binghamton, New York, United States

πŸ‡¨πŸ‡¦

Georgian Bay General Hospital, Penetanguishene/Midland, Ontario, Canada

and more 2 locations

Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
First Posted Date
2007-12-10
Last Posted Date
2020-09-01
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
36
Registration Number
NCT00570180
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute 11560 University Ave, Edmonton, Alberta, Canada

πŸ‡¨πŸ‡¦

Queen Elizabeth II Health Sciences Centre., Halifax, Nova Scotia, Canada

πŸ‡¨πŸ‡¦

The Ottawa Hospital, Ottawa, Ontario, Canada

and more 4 locations

Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder

Phase 3
Completed
Conditions
Major Depressive Disorder
Interventions
Drug: Diluent / Insulin
Drug: Insulin / Diluent
First Posted Date
2007-12-10
Last Posted Date
2015-02-24
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
35
Registration Number
NCT00570050
Locations
πŸ‡¨πŸ‡¦

Toronto Western Hospital, Toronto, Ontario, Canada

Β© Copyright 2025. All Rights Reserved by MedPath